Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference
BOULDER, Colo., Jan. 6, 2016 /PRNewswire/ — Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Annual J.P. Morgan Healthcare Conference Presenter: Ron Squarer, Chief Executive Officer, Array BioPharma Date: Wednesday, January 13, 2016 Time: 4:00 p.m. Pacific Time Location: Westin St. Francis Hotel, San Francisco Webcast: www.arraybiopharma.com
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto Array BioPharma Inc. 303-386-1193 firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300199899.html
SOURCE Array BioPharma Inc.
STOCK SYMBOL: – NASDAQ-NMS:ARRY
Company – Array BioPharma Inc.
Location: Colorado (GeographyCode)